diltiazem has been researched along with captopril in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (13.73) | 18.7374 |
| 1990's | 25 (49.02) | 18.2507 |
| 2000's | 11 (21.57) | 29.6817 |
| 2010's | 8 (15.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Endo, T; Koshiba, K; Kumano, K | 1 |
| Frei, U; Koch, KM; Matthies, C; Schindler, R | 1 |
| Ichikawa, S; Murata, K; Nakamura, T; Ono, Z; Sakamaki, T; Sato, K; Yagi, A | 1 |
| Braunwald, E; Hamm, P; Lamas, GA; Pfeffer, MA; Rouleau, JL; Wertheimer, J | 1 |
| Endo, T; Kumano, K; Kuwao, S; Wang, G | 1 |
| Cappuccio, FP; MacGregor, GA; Markandu, ND; Singer, DR | 1 |
| Chang, MS; Chen, SA; Cheng, KK; Chiang, BN; Lin, CI | 1 |
| Toshima, H | 1 |
| Raij, L; Tolins, JP | 1 |
| Davis, WR; DiPette, DJ; Evans, RR; Holland, OB; Wallace, JM | 1 |
| Davis, WR; DiPette, DJ; Evans, RR; Graham, GA; Green, A; Holland, OB; Townsend, R; Wallace, JM | 1 |
| Bernheim, J; Kariv, N; Podjarny, E; Pomeranz, A; Rathaus, M; Shapira, J; Zadok, S | 1 |
| Boucher, S; Lacourcière, Y; Poirier, L; Spenard, J | 1 |
| Ram, CV | 1 |
| Ivleva, AIa; Krasnobaeva, GM; Lepakhin, VK; Moiseev, VS; Ogoliuk, LIu | 1 |
| Cerný, J; Dostál, M; Gregor, Z; Guba, P; Rebícek, J; Sotolová, O; Urbánek, P; Vasků, A; Vasků, J | 1 |
| Abernethy, D; DiPette, DJ; Wolfson, P; Zusman, R | 1 |
| Drexler, H; Just, H; Truog, AG; Zelis, R | 1 |
| Clark, RL; Hillman, BJ; Lee, SM; Michael, UF | 1 |
| Acconcia, MC; Gaspardone, A; Pannarale, G; Valente, A | 1 |
| Britton, LW; Ferraris, VA; Kiser, LM; Sim, MF; Wallace, AM; Weishaar, RE | 1 |
| Collins, TJ; Mehra, MR; Ramee, SR; Smart, FW; Stapleton, DD; Ventura, HO | 1 |
| Ali, BH; Bashir, AA | 1 |
| Bernheim, J; Bernheim, JL; Green, J; Podjarny, E; Pomeranz, A; Pomeranz, M; Rathaus, M | 1 |
| Cushman, WC; Freis, ED; Fye, C; Gottdiener, J; Hamburger, RJ; Kochar, MS; Lakshman, R; Massie, BM; Materson, BJ; Reda, DJ | 1 |
| Bujor, MA; Davis, BB; Myles, PS; Olenikov, I | 1 |
| Allen, LV; Erickson, MA | 1 |
| Anderson, RJ; Gottdiener, JS; Massie, BM; Materson, BJ; Reda, DJ; Williams, DW | 1 |
| Pojoga, L; Raicu, M; Simionescu, M; Simionescu, N | 1 |
| Mandal, TK | 1 |
| Berglund, E; Dahlöf, C; Engqvist, L; Lagerstedt, C; Lehtonen, A; Nilsson-Ehle, P; Thulin, T | 1 |
| Cushman, WC; Freis, ED; Lakshman, MR; Materson, BJ; Reda, DJ | 1 |
| Cushman, WC; Materson, BJ; Reda, DJ; Williams, DW | 1 |
| Hansson, L; Hildebrandt, PR; Kjeldsen, SE; Lund-Johansen, P; Tuxen, CD | 1 |
| Leenen, FH; Ruzicka, M | 1 |
| Aronow, WS; Frishman, WH | 1 |
| Carrera, MJ; Micaló, T; Montanya, E; Pérez-Maraver, M; Sahun, M; Soler, J; Vinzia, C | 1 |
| Chen, CC; Dahly-Vernon, AJ; Dunn, KM; Ledbetter, SR; Murphy, SR; Roman, RJ; Williams, JM | 1 |
| Ala, S; Alvandipour, M; Enayatifard, R; Qobadighadikolaei, R | 1 |
6 review(s) available for diltiazem and captopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Calcium antagonists in the treatment of hypertension.
Topics: Biological Transport, Active; Calcium; Calcium Channel Blockers; Captopril; Diltiazem; Diuretics; Drug Resistance; Drug Therapy, Combination; Electrophysiology; Humans; Hypertension; Hypertension, Renovascular; Ion Channels; Kinetics; Methyldopa; Muscle, Smooth, Vascular; Nifedipine; Propranolol; Sodium; Vascular Resistance; Verapamil | 1985 |
[Early pulmonary hypertension: current therapeutic prospectives].
Topics: Calcium Channel Blockers; Captopril; Diazoxide; Diltiazem; Humans; Hydralazine; Hypertension, Pulmonary; Isoproterenol; Nifedipine; Phentolamine; Time Factors | 1982 |
[Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Diltiazem; Humans; Hypertension; Hypolipidemic Agents; Middle Aged; Nifedipine; Prospective Studies; Randomized Controlled Trials as Topic | 2001 |
Combination therapy as first-line treatment of arterial hypertension.
Topics: Antihypertensive Agents; Atenolol; Captopril; Diltiazem; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Prazosin; Treatment Outcome | 2002 |
Treatment of hypertension and prevention of ischemic stroke.
Topics: Algorithms; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diltiazem; Humans; Hypertension; Losartan; Perindopril; Stroke | 2004 |
12 trial(s) available for diltiazem and captopril
| Article | Year |
|---|---|
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators.
Topics: Adult; Aged; Aspirin; Calcium Channel Blockers; Captopril; Cardiomegaly; Cardiovascular Agents; Diltiazem; Drug Utilization; Female; Humans; Male; Middle Aged; Myocardial Infarction; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Survival Rate; Time Factors; United States | 1992 |
Studies of captopril alone and in combination with the benzothiazepine diltiazem or the dihydropyridine nifedipine in treating essential hypertension.
Topics: Adult; Aged; Blood Pressure; Captopril; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Nifedipine; Single-Blind Method | 1991 |
Effects of calcium channel blockade on calcium homeostasis in mild to moderate essential hypertension.
Topics: Adult; Aged; Blood Pressure; Calcium; Calcium Channel Blockers; Captopril; Diltiazem; Female; Homeostasis; Humans; Hypertension; Male; Middle Aged; Parathyroid Hormone; Renin | 1990 |
Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study.
Topics: Adolescent; Adult; Aged; Apolipoproteins; Blood Pressure; Captopril; Delayed-Action Preparations; Diltiazem; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Humans; Hypertension; Lipids; Lipoproteins; Middle Aged | 1990 |
Diltiazem and captopril alone or in combination for treatment of mild to moderate systemic hypertension.
Topics: Adult; Blood Pressure; Captopril; Clinical Trials as Topic; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Random Allocation | 1988 |
Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Age Factors; Aged; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Captopril; Clonidine; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin | 1993 |
Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Captopril; Clonidine; Cohort Studies; Diltiazem; Diuretics; Double-Blind Method; Echocardiography; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardium; Organ Size; Prazosin; Prevalence; Risk Factors; Sodium Chloride Symporter Inhibitors; Treatment Outcome; United States; United States Department of Veterans Affairs | 1997 |
Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study Group.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Diltiazem; Humans; Hypertension; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Quality of Life; Single-Blind Method; Time Factors; Uric Acid | 1999 |
Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Clonidine; Diltiazem; Diuretics; Double-Blind Method; Hospitals, Veterans; Humans; Hydrochlorothiazide; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Potassium; Prazosin; Time Factors; Treatment Outcome; United States | 1999 |
Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Clonidine; Diastole; Diltiazem; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin; Pressure; Pulse; Randomized Controlled Trials as Topic; Systole; Time Factors; Treatment Outcome | 2001 |
Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment.
Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Prospective Studies | 2005 |
Comparison of captopril (0.5%) cream with diltiazem (2%) cream for chronic anal fissure: a prospective randomized double-blind two-centre clinical trial.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anal Canal; Captopril; Chronic Disease; Defecation; Diltiazem; Double-Blind Method; Female; Fissure in Ano; Humans; Male; Middle Aged; Pain Measurement; Prospective Studies; Pruritus Ani; Treatment Outcome; Vasodilator Agents; Young Adult | 2016 |
33 other study(ies) available for diltiazem and captopril
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Functional and morphological changes in rat kidney induced by FK506 and its reversal by various vasodilators].
Topics: Animals; Calcium; Captopril; Diltiazem; Hemodynamics; Kidney; Male; Necrosis; Prazosin; Rats; Rats, Inbred Strains; Tacrolimus | 1992 |
Glomerular hemodynamics of the clipped kidney: effects of captopril and diltiazem.
Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Diltiazem; Glomerular Filtration Rate; Hemodynamics; Hypertension, Renovascular; Kidney Glomerulus; Male; Punctures; Rats; Rats, Inbred Strains; Vascular Resistance | 1992 |
Role of norepinephrine in the lack of reflex tachycardia after angiotensin converting enzyme inhibitor treatment.
Topics: Animals; Blood Pressure; Captopril; Diltiazem; Heart Rate; Hemodynamics; Male; Norepinephrine; Pressoreceptors; Rabbits; Reflex; Tachycardia | 1992 |
FK 506-induced nephrotoxicity in rats.
Topics: Animals; Anti-Bacterial Agents; Blood Pressure; Captopril; Diltiazem; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Male; Organ Size; Prazosin; Rats; Rats, Inbred Strains; Reference Values; Renal Circulation; Tacrolimus; Vascular Resistance | 1991 |
Electromechanical effects of angiotensin in human atrial tissues.
Topics: Action Potentials; Adolescent; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Function; Captopril; Child; Diltiazem; Female; Heart Atria; Humans; Male; Microelectrodes; Middle Aged; Myocardial Contraction; Saralasin | 1991 |
[Progress in the treatment of myocardial diseases].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Diltiazem; Echocardiography; Electrocardiography; Female; Humans; Male; Middle Aged; Verapamil | 1990 |
Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Captopril; Diltiazem; Glomerular Filtration Rate; Hypertension; Kidney Failure, Chronic; Kidney Glomerulus; Male; Nephrectomy; Proteinuria; Rats; Rats, Inbred Strains; Thiazepines; Triglycerides | 1990 |
Humoral factors determining the blood pressure response to converting enzyme inhibition and calcium channel blockade.
Topics: Adult; Aged; Blood Pressure; Captopril; Delayed-Action Preparations; Diltiazem; Epinephrine; Humans; Hypertension; Middle Aged; Norepinephrine; Renin | 1990 |
Captopril, but not diltiazem, favorably affects the course of early chronic renal disease in rats.
Topics: Animals; Calcium; Captopril; Diltiazem; Doxorubicin; Hypertension; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Male; Prostaglandins; Proteinuria; Rats; Rats, Inbred Strains | 1990 |
[Hemodynamic effects of the treatment of hypertension with the calcium channel blocker diltiazem].
Topics: Adult; Aged; Antihypertensive Agents; Captopril; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged | 1989 |
[Therapy of venous hypertension in animals with an artificial heart and long-term survival].
Topics: Animals; Antihypertensive Agents; Captopril; Cattle; Clonidine; Diltiazem; Heart, Artificial; Methyldopa; Nifedipine; Prazosin; Venous Pressure | 1989 |
[Modification of organ perfusion by calcium blocker and converting enzyme inhibitor in the conscious rat with heart failure].
Topics: Animals; Benzazepines; Captopril; Coronary Circulation; Digestive System; Diltiazem; Heart Failure; Hemodynamics; Male; Muscles; Myocardial Infarction; Physical Exertion; Proline; Rats; Rats, Inbred Strains; Regional Blood Flow; Renal Circulation; Skin | 1985 |
The effects of diltiazem and captopril on glycerol-induced acute renal failure in the rat. Functional, pathologic, and microangiographic studies.
Topics: Acute Kidney Injury; Angiography; Animals; Benzazepines; Captopril; Diltiazem; Glycerol; Kidney; Male; Microcirculation; Rats; Rats, Inbred Strains; Time Factors | 1985 |
Assessment of flosequinan's direct effect on human arterial, venous, and cardiac muscle: comparison with other classes of agents used to treat heart failure.
Topics: Captopril; Diltiazem; Heart Failure; Humans; In Vitro Techniques; Milrinone; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Ouabain; Pyridones; Quinolines; Quinolones; Vasodilator Agents | 1994 |
An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Coronary Disease; Diltiazem; Enalapril; Female; Heart Transplantation; Humans; Hyperplasia; Lisinopril; Male; Middle Aged; Nifedipine; Transplantation, Homologous; Tunica Intima; Ultrasonography, Interventional; Verapamil | 1995 |
Comparative modulating effects of captopril, diltiazem, dietary calcium and pyridoxal-5'-phosphate on gentamicin-induced nephrotoxicity in the rat.
Topics: Animals; Body Weight; Calcium, Dietary; Captopril; Diltiazem; Female; Gentamicins; Glutathione; Injections, Intramuscular; Kidney Cortex; Kidney Diseases; Kidney Function Tests; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley | 1993 |
Effect of timing of antihypertensive therapy on glomerular injury: comparison between captopril and diltiazem.
Topics: Animals; Captopril; Diltiazem; Doxorubicin; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; Time Factors | 1993 |
ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case-control study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Cardiopulmonary Bypass; Case-Control Studies; Coronary Artery Bypass; Critical Care; Diltiazem; Dopamine; Enalapril; Female; Heart Valves; Humans; Length of Stay; Male; Middle Aged; Nifedipine; Norepinephrine; Retrospective Studies; Single-Blind Method; Syndrome; Vascular Resistance; Verapamil | 1993 |
Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids.
Topics: Baclofen; Captopril; Chromatography, High Pressure Liquid; Diltiazem; Dipyridamole; Drug Compounding; Drug Stability; Drug Storage; Flecainide; Solutions; Temperature | 1996 |
The effect of ACE inhibitors on atheroma formation is potentiated by association with a calcium channel blocker. A biochemical and ultrastructural study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve; Arteriosclerosis; Calcium Channel Blockers; Captopril; Cholesterol; Coronary Vessels; Cricetinae; Diet, Atherogenic; Diltiazem; Drug Synergism; Enalapril; Male; Maleates; Mesocricetus; Microscopy, Electron | 1997 |
Evaluation of a novel phase separation technique for the encapsulation of water-soluble drugs in biodegradable polymer.
Topics: Adrenergic beta-Antagonists; Antifungal Agents; Antihypertensive Agents; Biodegradation, Environmental; Calcium Channel Blockers; Captopril; Diltiazem; Drug Compounding; Drug Delivery Systems; Evaluation Studies as Topic; Lactic Acid; Metoprolol; Pentamidine; Polyesters; Polyglycolic Acid; Polymers; Solubility; Water | 1998 |
Renoprotective effects of anti-TGF-β antibody and antihypertensive therapies in Dahl S rats.
Topics: Acute Kidney Injury; Animals; Antibodies, Anti-Idiotypic; Antihypertensive Agents; Blood Pressure; Captopril; Diltiazem; Disease Models, Animal; Female; Fibrosis; Hydrochlorothiazide; Hypertension; Male; Proteinuria; Rats; Rats, Inbred Dahl; Sex Characteristics; Sodium Chloride, Dietary; Transforming Growth Factor beta | 2012 |